Cardiometabolic Risk Factors and Atrial Fibrillation

被引：16

作者：

Menezes, Arthur R. ^{[1
]}

Lavie, Carl J. ^{[1
,2
]}

DiNicolantonio, James J. ^{[3
]}

O'Keefe, James ^{[4
]}

Morin, Daniel P. ^{[1
]}

Khatib, Sammy ^{[1
]}

Messerli, Franz H. ^{[5
]}

Milani, Richard V. ^{[1
]}

机构：

[1] Univ Queensland Sch Med, Dept Cardiovasc Dis, John Ochsner Heart & Vasc Inst, Ochsner Clin Sch, New Orleans, LA 70121 USA

[2] Louisiana State Univ Syst, Dept Preventat Cardiol, Pennington Biomed Res Ctr, Baton Rouge, LA USA

[3] Wegmans Pharm, Ithaca, NY USA

[4] St Lukes Mid Amer Heart Inst, Kansas City, MO USA

[5] St Lukes Roosevelt Hosp, New York, NY USA

来源：

REVIEWS IN CARDIOVASCULAR MEDICINE | 2013年 / 14卷 / 2-4期

关键词：

Atrial fibrillation; Metabolic syndrome; Obesity; Hypertension; Diabetes; RENIN-ANGIOTENSIN SYSTEM; CONVERTING ENZYME-INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; II RECEPTOR BLOCKERS; NUTRITION EXAMINATION SURVEY; NIIGATA PREVENTIVE MEDICINE; PULMONARY VEIN ISOLATION; OBSTRUCTIVE SLEEP-APNEA; BODY-MASS INDEX; METABOLIC SYNDROME;

D O I：

10.3909/ricm0693

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) is the most common arrhythmia worldwide; it is a significant risk factor for stroke and embolization, and has an impact on cardiac function. Despite its impact on morbidity and mortality, our understanding of the etiology and pathophysiology of this disease process is still incomplete. Over the past several decades, there has been evidence to suggest that AF has a significant correlation with metabolic syndrome (MetS). Furthermore, AF appears to be more closely related to specific components of MetS compared with others. This article provides an overview of the various components of MetS and their impact on AF.

引用

页码：E73 / E81

页数：9

共 50 条

[1] CARDIOMETABOLIC RISK FACTORS FOR ATRIAL FIBRILLATION IN TYPE 2 DIABETES MELLITUS
Gaman, M.
Dobrica, E. C.
Pascu, E. G.
Cozma, M. A.
Epingeac, M. E.
Gaman, A. M.
Diaconu, C. C.
[J]. JOURNAL OF HYPERTENSION, 2019, 37 : E96 - E96
[2] Cardiometabolic Risk Factors and Atrial Fibrillation (vol 15, pg 74, 2014)
Menezes, Arthur R.
Lavie, Carl J.
DiNicolantonio, James J.
O'Keefe, James
Morin, Daniel P.
Khatib, Sammy
Abi-Samra, Freddy M.
Messerli, Franz H.
Milani, Richard V.
[J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2014, 15 (01) : 74 - 74
[3] Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
Rafaqat, Saira
Sharif, Saima
Naz, Shagufta
Gluscevic, Sanja
Mercantepe, Filiz
Ninic, Ana
Klisic, Aleksandra
[J]. MEDICINA-LITHUANIA, 2024, 60 (08):
[4] Atrial fibrillation in the cardiometabolic patient
De Sensi, Francesco
Costantino, Sarah
Limbruno, Ugo
Paneni, Francesco
[J]. MINERVA MEDICA, 2019, 110 (02) : 157 - 167
[5] Risk factors of the atrial fibrillation progression in patients with recurrent atrial fibrillation
Ganiyev, T. Z. Tohir
Zakirov, N. U.
Kurbanov, R. D.
Irisov, D. B.
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 468 - 468
[6] ATRIAL FIBRILLATION Atrial fibrillation and rheumatoid arthritis are cardiovascular risk factors
Hippisley-Cox, Julia
Coupland, Carol
Robson, John
Brindle, Peter
[J]. BRITISH MEDICAL JOURNAL, 2012, 344
[7] Modifiable Risk Factors and Atrial Fibrillation
Lau, Dennis H.
Nattel, Stanley
Kalman, Jonathan M.
Sanders, Prashanthan
[J]. CIRCULATION, 2017, 136 (06) : 583 - 596
[8] Risk Factors and Genetics of Atrial Fibrillation
Anumonwo, Justus M. B.
Kalifa, Jerome
[J]. CARDIOLOGY CLINICS, 2014, 32 (04) : 485 - +
[9] Risk factors for recurrence of atrial fibrillation
Kisheva, Antoniya
YOtov, Yoto
[J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2021, 25 (05): : 338 - 345
[10] Risk Factors and Genetics of Atrial Fibrillation
Anumonwo, Justus M. B.
Kalifa, Jerome
[J]. HEART FAILURE CLINICS, 2016, 12 (02) : 157 - +

← 1 2 3 4 5 →